Active Ingredient History

  • Now
Rifaximin is a structural analog of rifampin and a non-systemic, gastrointestinal site-specific antibiotic. Rifaximin acts by inhibiting bacterial ribonucleic acid (RNA) synthesis and contributes to restore intestinal microflora imbalance. It is FDA approved for the treatment of travelers’ diarrhea, reduction in risk of overt hepatic encephalopathy (HE) recurrence and treatment of irritable bowel syndrome with diarrhea. More common side effects are: black, tarry stools; dizziness or lightheadedness; muscle spasm; rapid breathing; shortness of breath; trouble sleeping. Co-administration of cyclosporine, with XIFAXAN resulted in 83-fold and 124-fold increases in rifaximin mean Cmax in healthy subjects.   NCATS

  • SMILES: CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C4=C5N=C6C=C(C)C=CN6C5=C(NC(=O)C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
  • Mol. Mass: 785.8785
  • ALogP: 6.16
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$14.3870 - $44.0567
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

4-deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4c)rifamycin | l 105 | l-105 | normix | redactiv | refaximin | rifacol | rifamycin l 105 | rifamycin l 105sv | rifaxidin | rifaximin | rifaximina | rifaximine | rifaximinum | rifaximinun | rifaximin (xifaxan) | targaxan | xifaxan | xifaxanta | xifaxsan


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue